Hydrophobic Photolabeling Studies Identify the Lipid-protein Interface of the 5-HT3A Receptor

Overview

Journal Biochemistry

Specialty Biochemistry

Date 2009 Sep 1

PMID 19715355

Citations 4

Authors

Mitesh Sanghvi

Ayman K Hamouda

Margaret I Davis

Russell A Morton

Shouryadeep Srivastava

Akash Pandhare

Phaneendra K Duddempudi

Tina K Machu

David M Lovinger

Jonathan B Cohen

Michael P Blanton

Affiliations

Soon will be listed here.

Abstract

A HEK-293 cell line that stably expresses mouse 5-HT(3A)Rs containing a C-terminal extension that confers high-affinity binding of alpha-bungarotoxin (alphaBgTx) was established (alphaBgTx-5-HT(3A)Rs) and used to purify alphaBgTx-5-HT(3A)Rs in a lipid environment for use in structural studies using photoaffinity labeling. alphaBgTx-5-HT(3A)Rs were expressed robustly (60 pmol of [(3)H]BRL-43694 binding sites (approximately 3 microg of receptor) per milligram of protein) and displayed the same functional properties as wild-type receptors (serotonin EC(50) = 5.3 +/- 0.04 microM). While [(125)I]alphaBgTx bound to the alphaBgTx-5-HT(3A)Rs with high affinity (K(d) = 11 nM), application of nonradioactive alphaBgTx (up to 300 microM) had no effect on serotonin-induced current responses. alphaBgTx-5-HT(3A)Rs were purified on an alphaBgTx-derivatized affinity column from detergent extracts in milligram quantities and at approximately 25% purity. The hydrophobic photolabel 3-trifluoromethyl-3-(m-[(125)I]iodophenyl)diazirine ([(125)I]TID) was used to identify the amino acids at the lipid-protein interface of purified and lipid-reconstituted alphaBgTx-5-HT(3A)Rs. [(125)I]TID photoincorporation into the alphaBgTx-5-HT(3A)R subunit was initially mapped to subunit proteolytic fragments of 8 kDa, containing the M4 transmembrane segment and approximately 60% of incorporated (125)I, and 17 kDa, containing the M1-M3 transmembrane segments. Within the M4 segment, [(125)I]TID labeled Ser(451), equivalent to the [(125)I]TID-labeled residue Thr(422) at the lipid-exposed face of the Torpedo nicotinic acetylcholine receptor (nAChR) alpha1M4 alpha-helix. These results provide a first definition of the surface of the 5-HT(3A)R M4 helix that is exposed to lipid and establish that this surface is equivalent to the surface exposed to lipid in the Torpedo nAChR.

Citing Articles

The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors.

Pandhare A, Pappu A, Wilms H, Blanton M, Jansen M Neuropharmacology. 2016; 113(Pt A):89-99.

PMID: 27671323 PMC: 5148637. DOI: 10.1016/j.neuropharm.2016.09.021.

Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors.

Morton R, Baptista-Hon D, Hales T, Lovinger D Br J Pharmacol. 2015; 172(16):4066-77.

PMID: 25989383 PMC: 4543613. DOI: 10.1111/bph.13197.

Fluorophore assisted light inactivation (FALI) of recombinant 5-HT₃A receptor constitutive internalization and function.

Morton R, Luo G, Davis M, Hales T, Lovinger D Mol Cell Neurosci. 2011; 47(2):79-92.

PMID: 21338684 PMC: 3172681. DOI: 10.1016/j.mcn.2011.02.007.

High-level expression and purification of Cys-loop ligand-gated ion channels in a tetracycline-inducible stable mammalian cell line: GABAA and serotonin receptors.

Dostalova Z, Liu A, Zhou X, Farmer S, Krenzel E, Arevalo E Protein Sci. 2010; 19(9):1728-38.

PMID: 20662008 PMC: 2975136. DOI: 10.1002/pro.456.

References

McKernan R, Gillard N, Quirk K, Kneen C, Stevenson G, Swain C . Purification of the 5-hydroxytryptamine 5-HT3 receptor from NCB20 cells. J Biol Chem. 1990; 265(23):13572-7. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Lambert J, Peters J, Hales T, Dempster J . The properties of 5-HT3 receptors in clonal cell lines studied by patch-clamp techniques. Br J Pharmacol. 1989; 97(1):27-40. PMC: 1854480. DOI: 10.1111/j.1476-5381.1989.tb11920.x. View

Hoyer D, Neijt H . Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding. Mol Pharmacol. 1988; 33(3):303-9. View

Morales M, Wang S . Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system. J Neurosci. 2002; 22(15):6732-41. PMC: 6758137. DOI: 20026612. View

Maricq A, Peterson A, Brake A, Myers R, Julius D . Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science. 1991; 254(5030):432-7. DOI: 10.1126/science.1718042. View

Price K, Lummis S . The role of tyrosine residues in the extracellular domain of the 5-hydroxytryptamine3 receptor. J Biol Chem. 2004; 279(22):23294-301. DOI: 10.1074/jbc.M314075200. View

Hamouda A, Sanghvi M, Chiara D, Cohen J, Blanton M . Identifying the lipid-protein interface of the alpha4beta2 neuronal nicotinic acetylcholine receptor: hydrophobic photolabeling studies with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine. Biochemistry. 2007; 46(48):13837-46. PMC: 2597459. DOI: 10.1021/bi701705r. View

Peters J, Hales T, Lambert J . Divalent cations modulate 5-HT3 receptor-induced currents in N1E-115 neuroblastoma cells. Eur J Pharmacol. 1988; 151(3):491-5. DOI: 10.1016/0014-2999(88)90550-x. View

10.

Sanders T, Hawrot E . A novel pharmatope tag inserted into the beta4 subunit confers allosteric modulation to neuronal nicotinic receptors. J Biol Chem. 2004; 279(49):51460-5. DOI: 10.1074/jbc.M409533200. View

11.

Schwartz R, Kellar K . In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem. 1985; 45(2):427-33. DOI: 10.1111/j.1471-4159.1985.tb04005.x. View

12.

WHITE B, Cohen J . Agonist-induced changes in the structure of the acetylcholine receptor M2 regions revealed by photoincorporation of an uncharged nicotinic noncompetitive antagonist. J Biol Chem. 1992; 267(22):15770-83. View

13.

Green T, Stauffer K, Lummis S . Expression of recombinant homo-oligomeric 5-hydroxytryptamine3 receptors provides new insights into their maturation and structure. J Biol Chem. 1995; 270(11):6056-61. DOI: 10.1074/jbc.270.11.6056. View

14.

Engleman E, Rodd Z, Bell R, Murphy J . The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy. CNS Neurol Disord Drug Targets. 2009; 7(5):454-67. PMC: 2878195. DOI: 10.2174/187152708786927886. View

15.

Reeves D, Lummis S . The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review). Mol Membr Biol. 2002; 19(1):11-26. DOI: 10.1080/09687680110110048. View

16.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

17.

Blanton M, McCardy E, Fryer J, Liu M, Lukas R . 5-hydroxytryptamine interaction with the nicotinic acetylcholine receptor. Eur J Pharmacol. 2000; 389(2-3):155-63. DOI: 10.1016/s0014-2999(99)00855-9. View

18.

Hamouda A, Chiara D, Blanton M, Cohen J . Probing the structure of the affinity-purified and lipid-reconstituted torpedo nicotinic acetylcholine receptor. Biochemistry. 2008; 47(48):12787-94. PMC: 2872774. DOI: 10.1021/bi801476j. View

19.

Arevalo E, Chiara D, Forman S, Cohen J, Miller K . Gating-enhanced accessibility of hydrophobic sites within the transmembrane region of the nicotinic acetylcholine receptor's {delta}-subunit. A time-resolved photolabeling study. J Biol Chem. 2005; 280(14):13631-40. DOI: 10.1074/jbc.M413911200. View

20.

Chameau P, van Hooft J . Serotonin 5-HT(3) receptors in the central nervous system. Cell Tissue Res. 2006; 326(2):573-81. DOI: 10.1007/s00441-006-0255-8. View